FDA releases draft guidance for protecting children in clinical trials

The US Food and Drug Administration (FDA) has released a new draft guidance which is aimed at protecting children who take part in clinical trials.

Developed by the FDA’s Office of Pediatric Therapeutics, the guidance named ‘Ethical Considerations for Clinical Investigations of Medical Products Involving Children’, will also provide the perspective of the agency on the ethical considerations to include children in trials, once finalised.